Nano-X Imaging Ltd. (NNOX)
Stock Price:
$34.88 USD
6.78 (24.13%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed
After-hours: $35.38 +0.50 (1.43%) Sep 18, 7:59 PM
Key Info
| Market Cap |
1.56B |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-34.67M |
| Shares Out |
44.76M |
| EPS (ttm) |
-0.84 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Sep 18, 2020 |
| Last Price |
$34.88 |
| Previous Close |
$28.10 |
| Change ($) |
6.78 |
| Change (%) |
24.13% |
| Day's Open |
31.06 |
| Day's Range |
29.33 - 35.97 |
| Day's Volume |
9,614,776 |
| 52-Week Range |
20.26 - 66.67 |
More Stats
| Market Cap |
1.56B |
| Enterprise Value |
1.52B |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
44.76M |
| Float |
30.78M |
| EPS (basic) |
n/a |
| EPS (diluted) |
-0.84 |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
510,284 |
| Short Ratio |
0.16 |
| Short % of Float |
1.42% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
31.16 |
| Revenue |
n/a |
| Operating Income |
n/a |
| Net Income |
-34.67M |
| Free Cash Flow |
n/a |
| Net Cash |
38.59M |
| Net Cash / Share |
0.86 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
n/a |
| ROE |
n/a |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (3)
| Buy |
2 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$67.50*
(93.52% upside)
Low
65.0
Current: $34.88
High
70.0
Target: 67.50
*Average 12-month price target from 2 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 |
|---|
| Revenue | - | - |
| Operating Income | -22.57 | -1.90 |
| Net Income | -22.56 | -1.91 |
| Shares Outstanding | 25.18 | 20.79 |
| Earnings Per Share | -0.90 | -0.09 |
| Operating Cash Flow | -5.52 | -3.67 |
| Capital Expenditures | -0.13 | -0.07 |
| Free Cash Flow | -5.65 | -3.74 |
| Cash & Equivalents | 8.07 | 0.01 |
| Total Debt | 0.53 | - |
| Net Cash / Debt | 7.55 | 0.01 |
| Assets | 11.87 | 1.86 |
| Liabilities | 20.65 | 8.24 |
| Book Value | -8.78 | -6.38 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Nano-X Imaging Ltd. |
| Country |
Israel |
| Employees |
27 |
| CEO |
Ran Poliakine |
Stock Information
| Ticker Symbol |
NNOX |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: NNOX |
| IPO Date |
August 21, 2020 |
Description
Nano-X Imaging Ltd. engages in developing and producing X-ray source technology for the medical imaging industry in the United States. It develops novel digital X-ray source, a microelectromechanical system-based semiconductor cathode that achieves electron emission by a non-thermionic low-voltage trigger to nano-scale molybdenum cones. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud software designed to deliver medical screening as a service. Nano-X Imaging Ltd. was incorporated in 2018 and is based in Neve Ilan, Israel. Address: Communications Center, Neve Ilan, Israel, 9085000